MAB002) followed by Anti-Mouse IgG PE-conjugated Secondary Antibody (
F0102B) and Mouse anti-Human CD3 APC-conjugated Monoclonal Antibody (
FAB100A). To facilitate intracellular staining, cells were fixed with Flow Cytometry Fixation Buffer (
FC004) and permeabilized with Flow Cytometry Permeabilization/Wash Buffer I (
FC005). Staining was performed using our Staining Intracellular Molecules protocol." class="big_lightbox">

MAB002) followed by Anti-Mouse IgG PE-conjugated Secondary Antibody (
F0102B) and Mouse anti-Human CD3 APC-conjugated Monoclonal Antibody (
FAB100A). To facilitate intracellular staining, cells were fixed with Flow Cytometry Fixation Buffer (
FC004) and permeabilized with Flow Cytometry Permeabilization/Wash Buffer I (
FC005). Staining was performed using our Staining Intracellular Molecules protocol." alt="Human peripheral blood mononuclear cells (PBMCs) treated with PMA and Ca2+ionomycin for 3.5 hours were stained with (A) Mouse Anti-Human TNF-alpha Monoclonal Antibody (Catalog # MAB10564) or (B) isotype control antibody (
MAB002) followed by Anti-Mouse IgG PE-conjugated Secondary Antibody (
F0102B) and Mouse anti-Human CD3 APC-conjugated Monoclonal Antibody (
FAB100A). To facilitate intracellular staining, cells were fixed with Flow Cytometry Fixation Buffer (
FC004) and permeabilized with Flow Cytometry Permeabilization/Wash Buffer I (
FC005). Staining was performed using our Staining Intracellular Molecules protocol." class="big_thumb" />